Pages that link to "Q24536057"
Jump to navigation
Jump to search
The following pages link to Clindamycin as an antimalarial drug: review of clinical trials (Q24536057):
Displaying 50 items.
- Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria (Q17485067) (← links)
- Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria (Q24680404) (← links)
- Genetic reconstruction of protozoan rRNA decoding sites provides a rationale for paromomycin activity against Leishmania and Trypanosoma (Q28478249) (← links)
- Isoprenoid precursor biosynthesis offers potential targets for drug discovery against diseases caused by apicomplexan parasites (Q28727252) (← links)
- Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections (Q33589254) (← links)
- Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis. (Q33806574) (← links)
- Antimalarial compounds in Phase II clinical development. (Q34456807) (← links)
- Chemistry and biology of macrolide antiparasitic agents (Q34904340) (← links)
- Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant (Q35124138) (← links)
- New Antimalarial Drugs (Q35581916) (← links)
- In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species (Q35689416) (← links)
- Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis (Q35759007) (← links)
- Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria (Q35759028) (← links)
- Antimalarial combinations (Q35840382) (← links)
- Lincosamides: chemical structure, biosynthesis, mechanism of action, resistance, and applications (Q35964967) (← links)
- Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria (Q36018812) (← links)
- Parasite plastids: approaching the endgame (Q36052586) (← links)
- The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugs (Q36066272) (← links)
- Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets (Q36093316) (← links)
- Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast (Q36095096) (← links)
- Update on antimicrobial agents: new indications of older agents (Q36222046) (← links)
- Macrolides and associated antibiotics based on similar mechanism of action like lincosamides in malaria (Q36577718) (← links)
- Case management of malaria in pregnancy (Q36717625) (← links)
- Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development (Q36832446) (← links)
- Assessment of safety of the major antimalarial drugs (Q36945007) (← links)
- Update on clindamycin in the management of bacterial, fungal and protozoal infections (Q36967293) (← links)
- In Vivo Efficacy and Tolerability of Artesunate-Azithromycin for the Treatment of Falciparum Malaria in Vietnam (Q37094433) (← links)
- FR-900098, an antimalarial development candidate that inhibits the non-mevalonate isoprenoid biosynthesis pathway, shows no evidence of acute toxicity and genotoxicity (Q37189932) (← links)
- Herbicidal properties of antimalarial drugs (Q37731378) (← links)
- Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy (Q37735182) (← links)
- New approaches in antimalarial drug discovery and development: a review (Q38059380) (← links)
- Transformation of saturated nitrogen-containing heterocyclic compounds by microorganisms. (Q38172427) (← links)
- New insight-guided approaches to detect, cure, prevent and eliminate malaria (Q38260909) (← links)
- Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, ran (Q38852223) (← links)
- History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon (Q39381315) (← links)
- In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum (Q39381330) (← links)
- Mutasynthesis of lincomycin derivatives with activity against drug-resistant staphylococci (Q41812922) (← links)
- New medicines for malaria (Q41936153) (← links)
- Quinine for the treatment of malaria in pregnancy (Q43149317) (← links)
- Cytokine profile of Plasmodium falciparum-specific T cells in non-immune malaria patients (Q44174178) (← links)
- Characterization of N-demethyllincosamide methyltransferases LmbJ and CcbJ. (Q44387963) (← links)
- Antimalarial interaction of quinine and quinidine with clarithromycin. (Q45907681) (← links)
- Clindamycin phosphate scavenges hydroxyl radical (Q46910797) (← links)
- Impact of Sickle Cell Trait and Naturally Acquired Immunity on Uncomplicated Malaria after Controlled Human Malaria Infection in Adults in Gabon (Q47271937) (← links)
- Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites. (Q48015411) (← links)
- Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis (Q48035625) (← links)
- Clindamycin hydrochloride and clindamycin phosphate: two drugs or one? A retrospective analysis of a spontaneous reporting system. (Q48221168) (← links)
- Non-Antifolate Antibiotics: Clindamycin, Doxycycline, Azithromycin and Fosmidomycin (Q58828669) (← links)
- Antibiotic-induced microbiome perturbations are associated with significant alterations to colonic mucosal immunity in rhesus macaques (Q91665846) (← links)
- The genomic architecture of antimalarial drug resistance (Q92231044) (← links)